The RGD peptide can recognize the αvβ3 receptor overexpressed on neurovascular endothelial cells and the Lf can recognize transferrin receptor (TFR) on the brain tumors to facilitate the nanoparticles crossing the BBB and then targeting tumor cells. The gene discussed is TFRC; the disease is neoplasm.